(Q42553065)
Statements
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group (English)
K I Pritchard
A H Paterson
N A Paul
S Fine
1 October 1996